Preventing RSV in Babies
Source: https://www.lung.org/lung-health-diseases/lung-disease-lookup/rsv?fbclid=IwAR1YBhv5ZxJP3edYAbMIb6GlWeJfwkiFY8cWquu5M69zyiHkmo0Ftm5tEmA
C.D.C. Shortens Isolation Period for People With Covid
Americans with Covid or other respiratory infections may return to daily activities if they don’t have a fever and their symptoms are improving. Americans with Covid or other respiratory infections need not isolate for five days before returning to work or school, the Centers for Disease Control and Prevention said […]
RSV Infection in Older Adults
Respiratory syncytial virus (RSV) causes respiratory infections in humans. What Are the Symptoms of RSV Infection? In most people, RSV causes mild cold-like symptoms of cough, runny nose, sore throat, headache, decreased appetite, and fever that typically last less than 5 days. However, in older adults, RSV can cause […]
A New Shot Prevents Serious Illness from RSV
Clinical trials show that a single injection of nirsevimab significantly reduces severe illness from respiratory syncytial virus, which sickens millions of kids each year. Nearly all children will be infected by respiratory syncytial virus, or RSV, by the time they turn 2. Most experience common cold symptoms and recover within […]
Who’s Eligible for the RSV Vaccine?
Approved by the FDA, the vaccine will soon be available for adults 60 or older Respiratory syncytial virus, known as RSV, is a lung infection that’s highly contagious. “RSV is the poster child for what’s called paramyxoviruses, which is a family of viruses that can cause mild infections,” says pediatric […]
FDA approves first vaccine for RSV, a moment six decades in the making
After a 60-year scientific quest, the world has its first vaccine to protect against respiratory syncytial virus, or RSV – and more are on the way. On Wednesday, the US Food and Drug Administration approved Arexvy, made by GSK, which is designed to be given as a single shot to […]
Cancer, Heart Disease Vaccines May Be Ready by 2030, Moderna Says
Vaccines for the world’s most deadly diseases, like cancer and heart disease, will likely be ready by 2030 and could save millions of lives, according to the top doctor at one the world’s leading drug companies. The announcement is yet another sign of what many are calling “the golden age” […]
RSV Infection Might Be Resuming Prepandemic Patterns
Before 2020, annual respiratory syncytial virus (RSV) epidemics tended to begin in October, peak in December, and end by April. But patterns changed after the pandemic began, according to US Centers for Disease Control and Prevention data collected between 2017 and 2023. No typical winter RSV epidemic occurred during 2020-2021. […]
Seasonality of Respiratory Syncytial Virus — United States, 2017–2023
Summary What is already known about this topic? In the United States, the timing of seasonal respiratory syncytial virus (RSV) epidemics (October–April) was disrupted during the COVID-19 pandemic. What is added by this report? RSV circulation was historically low during 2020–21 and began earlier and continued longer during 2021–22 than […]
Pediatricians and parents on the brink: This is their March 2020
In March 2020, as the Covid-19 pandemic swept across the United States, the nation’s pediatric providers and pediatric units immediately pitched in to treat adults sickened by this then-mysterious and deadly disease. But now that the pediatric community is facing its own March 2020 with the confluence of Covid-19, influenza, […]